255 related articles for article (PubMed ID: 35969791)
21. Recent advances in proteome-wide label-free target deconvolution for bioactive small molecules.
Sun J; Prabhu N; Tang J; Yang F; Jia L; Guo J; Xiao K; Tam WL; Nordlund P; Dai L
Med Res Rev; 2021 Nov; 41(6):2893-2926. PubMed ID: 33533067
[TBL] [Abstract][Full Text] [Related]
22. Identifying cellular targets of small-molecule probes and drugs with biochemical enrichment and SILAC.
Ong SE; Li X; Schenone M; Schreiber SL; Carr SA
Methods Mol Biol; 2012; 803():129-40. PubMed ID: 22065222
[TBL] [Abstract][Full Text] [Related]
23. Target identification for small bioactive molecules: finding the needle in the haystack.
Ziegler S; Pries V; Hedberg C; Waldmann H
Angew Chem Int Ed Engl; 2013 Mar; 52(10):2744-92. PubMed ID: 23418026
[TBL] [Abstract][Full Text] [Related]
24. Activity based chemical proteomics: profiling proteases as drug targets.
Heal WP; Wickramasinghe SR; Tate EW
Curr Drug Discov Technol; 2008 Sep; 5(3):200-12. PubMed ID: 18690889
[TBL] [Abstract][Full Text] [Related]
25. A brief introduction to chemical proteomics for target deconvolution.
Dong ZC; Wang Y; Yang F; Wan F
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6014-6026. PubMed ID: 36111901
[TBL] [Abstract][Full Text] [Related]
26. μMap Photoproximity Labeling Enables Small Molecule Binding Site Mapping.
Huth SW; Oakley JV; Seath CP; Geri JB; Trowbridge AD; Parker DL; Rodriguez-Rivera FP; Schwaid AG; Ramil C; Ryu KA; White CH; Fadeyi OO; Oslund RC; MacMillan DWC
J Am Chem Soc; 2023 Aug; 145(30):16289-16296. PubMed ID: 37471577
[TBL] [Abstract][Full Text] [Related]
27. Proteomic characterization of post-translational modifications in drug discovery.
Zhai LH; Chen KF; Hao BB; Tan MJ
Acta Pharmacol Sin; 2022 Dec; 43(12):3112-3129. PubMed ID: 36372853
[TBL] [Abstract][Full Text] [Related]
28. Decoding communication patterns of the innate immune system by quantitative proteomics.
Sukumaran A; Coish JM; Yeung J; Muselius B; Gadjeva M; MacNeil AJ; Geddes-McAlister J
J Leukoc Biol; 2019 Dec; 106(6):1221-1232. PubMed ID: 31556465
[TBL] [Abstract][Full Text] [Related]
29. Accelerating the Validation of Endogenous On-Target Engagement and In Cellulo Kinetic Assessment for Covalent Inhibitors of KRAS
Kantae V; Polanski R; Lewis HJ; Haider A; Barratt D; Srinivasan B
ACS Chem Biol; 2022 Aug; 17(8):2366-2376. PubMed ID: 35881961
[TBL] [Abstract][Full Text] [Related]
30. Application of chemical biology in target identification and drug discovery.
Zhu Y; Xiao T; Lei S; Zhou F; Wang MW
Arch Pharm Res; 2015 Sep; 38(9):1642-50. PubMed ID: 26242900
[TBL] [Abstract][Full Text] [Related]
31. Chemical genetics-based target identification in drug discovery.
Cong F; Cheung AK; Huang SM
Annu Rev Pharmacol Toxicol; 2012; 52():57-78. PubMed ID: 21819237
[TBL] [Abstract][Full Text] [Related]
32. Identification of protein binding partners of small molecules using label-free methods.
Saxena C
Expert Opin Drug Discov; 2016 Oct; 11(10):1017-25. PubMed ID: 27554241
[TBL] [Abstract][Full Text] [Related]
33. Profiling disease-selective drug targets: From proteomics to ligandomics.
Waduge P; Tian H; Webster KA; Li W
Drug Discov Today; 2023 Mar; 28(3):103430. PubMed ID: 36343915
[TBL] [Abstract][Full Text] [Related]
34. Chemoproteomic-enabled phenotypic screening.
Conway LP; Li W; Parker CG
Cell Chem Biol; 2021 Mar; 28(3):371-393. PubMed ID: 33577749
[TBL] [Abstract][Full Text] [Related]
35. Mesopore-assisted profiling strategies in clinical proteomics for drug/target discovery.
Savino R; Terracciano R
Drug Discov Today; 2012 Feb; 17(3-4):143-52. PubMed ID: 22016086
[TBL] [Abstract][Full Text] [Related]
36. A Photoaffinity Labeling-Based Chemoproteomics Strategy for Unbiased Target Deconvolution of Small Molecule Drug Candidates.
Thomas JR; Brittain SM; Lipps J; Llamas L; Jain RK; Schirle M
Methods Mol Biol; 2017; 1647():1-18. PubMed ID: 28808992
[TBL] [Abstract][Full Text] [Related]
37. Ligand and Target Discovery by Fragment-Based Screening in Human Cells.
Parker CG; Galmozzi A; Wang Y; Correia BE; Sasaki K; Joslyn CM; Kim AS; Cavallaro CL; Lawrence RM; Johnson SR; Narvaiza I; Saez E; Cravatt BF
Cell; 2017 Jan; 168(3):527-541.e29. PubMed ID: 28111073
[TBL] [Abstract][Full Text] [Related]
38. Functional Identification of Target by Expression Proteomics (FITExP) reveals protein targets and highlights mechanisms of action of small molecule drugs.
Chernobrovkin A; Marin-Vicente C; Visa N; Zubarev RA
Sci Rep; 2015 Jun; 5():11176. PubMed ID: 26052917
[TBL] [Abstract][Full Text] [Related]
39. Thermal Proteome Profiling for Drug Target Identification and Probing of Protein States.
Sauer P; Bantscheff M
Methods Mol Biol; 2023; 2718():73-98. PubMed ID: 37665455
[TBL] [Abstract][Full Text] [Related]
40. Advances in identification and validation of protein targets of natural products without chemical modification.
Chang J; Kim Y; Kwon HJ
Nat Prod Rep; 2016 May; 33(5):719-30. PubMed ID: 26964663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
